Single‐dose pharmacokinetic study comparing the pharmacokinetics of recombinant human chorionic gonadotropin in healthy Japanese and Caucasian women and recombinant human chorionic gonadotropin and urinary human chorionic gonadotropin in healthy Japanese women

PURPOSE: Recombinant hCG (r‐hCG) was approved in Japan in 2016. As a prerequisite for a Phase III study in Japan related to this approval, the pharmacokinetic (PK) profile of r‐hCG was investigated. METHODS: An open‐label, partly randomized, single‐center, single‐dose, group‐comparison, Phase I PK‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagchus, Wilhelmina, Wolna, Peter, Uhl, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768983/
https://www.ncbi.nlm.nih.gov/pubmed/29371821
http://dx.doi.org/10.1002/rmb2.12066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768983/
https://www.ncbi.nlm.nih.gov/pubmed/29371821
http://dx.doi.org/10.1002/rmb2.12066

Ejemplares similares